WRALLocalTechWire.com - Biotech

FDA panel urges more testing for diabetes drugs

Thu, 03 Jul 2008 07:14:19 -0400

Diabetes drugs should face tougher safety standards that could cost manufacturers millions but protect patients from unforeseen heart risks, a government panel has recommended.

Altea Therapeutics signs development deal worth up to $109M

Wed, 02 Jul 2008 13:28:42 -0400

Altea Therapeutics will work with pharmaceutical and medication delivery firm Hospira to develop a new product in a deal that could mean as much as $109 million for the Georgia-based firm.

LabCorp launches ovarian cancer screening test

Wed, 02 Jul 2008 14:38:09 -0400

Laboratory Corporation (NYSE: LH) is launching a screening test for ovarian cancer that targets women who are at high risk of developing the disease.